sulbactam has been researched along with Aspergillus Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Busch, DH; Dommasch, M; Feihl, S; Heim, M; Lahmer, T; Lukas, M; Querbach, C; Rothe, K; Schmid, RM; Schneider, G; Schneider, J; Spinner, CD; Treiber, M; Wallnöfer, F; Waschulzik, B; Wurst, M; Zink, A | 1 |
Carter, KD; Graham, SM | 1 |
2 other study(ies) available for sulbactam and Aspergillus Infection
Article | Year |
---|---|
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Stewardship; Aspergillosis; Azithromycin; Bacterial Infections; Cohort Studies; Coinfection; COVID-19; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Humans; Klebsiella Infections; Linezolid; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; SARS-CoV-2; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Vancomycin; Young Adult | 2021 |
Response of visual loss in allergic fungal sinusitis to oral corticosteroids.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Aspergillosis; Blindness; Female; Glucocorticoids; Humans; Prednisone; Sinusitis; Sulbactam | 2005 |